Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study. Zivadinov R, Ramanathan M, Ambrus J, Hussein S, Ramasamy DP, Dwyer MG, Bergsland N, Minagar A, Weinstock-Guttman B Neurol Res. 2012 Oct; 34(8):761-9. PMID: 22971466. Abstract CommentRecommendBookmarkWatch